Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2020 Filed Nov 12, 2020 21:08 UTC |
Coleman GlennExecutive Vice President & COO
|
SaleCommon Stock | 4,400 | $56.04 | $246,596.68 |
DisclosureSEC source: 0001209191-20-057912 · doc4.xml · nonDerivative · entry 3 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,494 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $56.00 to $56.135. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:08 UTC |
Coleman GlennExecutive Vice President & COO
|
SaleCommon Stock | 93 | $55.04 | $5,118.72 |
DisclosureSEC source: 0001209191-20-057912 · doc4.xml · nonDerivative · entry 2 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,894 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:08 UTC |
Coleman GlennExecutive Vice President & COO
|
SaleCommon Stock | 4,907 | $54.34 | $266,668.46 |
DisclosureSEC source: 0001209191-20-057912 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,987 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $54.005 to $54.95. Read SEC document |
| November 01, 2020 Filed Nov 3, 2020 21:13 UTC |
McBreen Michael J.EVP & President, CSS
|
Tax withholdingCommon Stock | 1,713 | $44.10 | $75,543.30 |
DisclosureSEC source: 0001209191-20-056592 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,938 Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:34 UTC |
Tru St Partnership, L.P.10% owner
|
SaleCommon Stock | 200,000 | $46.97 | $9,394,000.00 |
DisclosureSEC source: 0001209191-20-051288 · doc4.xml · nonDerivative · entry 1 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,091,205 F1 · shares: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $46.97 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. F1 · price: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $46.97 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 20:16 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 48 | $51.72 | $2,482.56 |
DisclosureSEC source: 0001209191-20-046777 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,679 Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 20:16 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 9 | $51.72 | $465.48 |
DisclosureSEC source: 0001209191-20-046777 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,727 Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 20:12 UTC |
Mosebrook JeffreySVP, Fin & Princ Acct Officer
|
SaleCommon Stock | 807 | $51.68 | $41,708.75 |
DisclosureSEC source: 0001209191-20-046774 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,644 F1 · price: The price shown above represents the weighted average price of the shares sold. The sale price range was $51.68 to $51.69. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 20:10 UTC |
Coleman GlennExecutive Vice President & COO
|
SaleCommon Stock | 5,000 | $52.27 | $261,342.50 |
DisclosureSEC source: 0001209191-20-046586 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,894 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.00 to $53.03. F1 · acquired: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 20:14 UTC |
Evoli LisaEVP & Chief HR Officer
|
GrantCommon Stock | 2,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044668 · doc4.xml · nonDerivative · entry 2 Evoli Lisa · CIK 0001661715 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,256 Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 20:14 UTC |
Evoli LisaEVP & Chief HR Officer
|
Tax withholdingCommon Stock | 286 | $47.75 | $13,656.50 |
DisclosureSEC source: 0001209191-20-044668 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,169 Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 20:11 UTC |
McBreen Michael J.EVP & President, CSS
|
Tax withholdingCommon Stock | 317 | $47.75 | $15,136.75 |
DisclosureSEC source: 0001209191-20-044667 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,651 Read SEC document |
| July 03, 2020 Filed Jul 7, 2020 22:32 UTC |
Mosebrook JeffreySVP, Fin & Princ Acct Officer
|
Tax withholdingCommon Stock | 507 | $48.72 | $24,701.04 |
DisclosureSEC source: 0000917520-20-000025 · primary_doc.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,451 Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:07 UTC |
Anderson Carrie LExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 2,776 | $48.65 | $135,052.40 |
DisclosureSEC source: 0001209191-20-040236 · doc4.xml · nonDerivative · entry 1 Anderson Carrie L · CIK 0001706446 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,661 Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 20:12 UTC |
CARUSO RICHARD E10% owner
|
SaleCommon Stock | 600,000 | $48.47 | $29,082,000.00 |
DisclosureSEC source: 0001209191-20-038142 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 10,291,205 F1 · kind: Trust Partnership contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $48.57 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 20:18 UTC |
Evoli LisaChief Human Resources Officer
|
SaleCommon Stock | 3,475 | $55.00 | $191,125.00 |
DisclosureSEC source: 0001209191-20-034969 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,455 Read SEC document |
| May 28, 2020 Filed May 28, 2020 20:07 UTC |
ESSIG STUARTDirector
|
SaleCommon Stock | 11,626 | $52.40 | $609,222.16 |
DisclosureSEC source: 0001209191-20-032572 · doc4.xml · nonDerivative · entry 3 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 923,706 F3 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.00 to $52.71. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:07 UTC |
ESSIG STUARTDirector
|
SaleCommon Stock | 89,479 | $52.13 | $4,664,629.75 |
DisclosureSEC source: 0001209191-20-032572 · doc4.xml · nonDerivative · entry 2 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,332 F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.00 to $52.62. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:07 UTC |
ESSIG STUARTDirector
|
SaleCommon Stock | 46,807 | $52.08 | $2,437,722.60 |
DisclosureSEC source: 0001209191-20-032572 · doc4.xml · nonDerivative · entry 1 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,024,811 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.00 to $52.38. Read SEC document |
| May 16, 2020 Filed May 20, 2020 20:06 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommkon Stock | 43 | $46.44 | $1,996.92 |
DisclosureSEC source: 0001209191-20-030862 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,736 Read SEC document |
| May 16, 2020 Filed May 20, 2020 20:06 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 9 | $46.44 | $417.96 |
DisclosureSEC source: 0001209191-20-030862 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,779 Read SEC document |
| May 13, 2020 Filed May 14, 2020 20:21 UTC |
ESSIG STUARTDirector
|
GrantCommon Stock | 5,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029190 · doc4.xml · nonDerivative · entry 3 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,071,618 Read SEC document |
| May 13, 2020 Filed May 14, 2020 20:21 UTC |
ESSIG STUARTDirector
|
GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029190 · doc4.xml · nonDerivative · entry 2 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,451 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:15 UTC |
HOWELL LLOYD JRDirector
|
GrantCommpon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029725 · doc4.xml · nonDerivative · entry 2 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,638 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:15 UTC |
HOWELL LLOYD JRDirector
|
GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029725 · doc4.xml · nonDerivative · entry 1 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,420 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:16 UTC |
BRADLEY KEITHDirector
|
GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029731 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,788 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:16 UTC |
BRADLEY KEITHDirector
|
GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029731 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,570 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:12 UTC |
Murphy Raymond G.Director
|
GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029721 · doc4.xml · nonDerivative · entry 2 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,035 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:12 UTC |
Murphy Raymond G.Director
|
GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029721 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,817 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:09 UTC |
HILL BARBARA BDirector
|
GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029714 · doc4.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,669 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:09 UTC |
HILL BARBARA BDirector
|
GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029714 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,451 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:11 UTC |
Ballintyn Rhonda GermanyDirector
|
GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029716 · doc4.xml · nonDerivative · entry 2 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,206 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:11 UTC |
Ballintyn Rhonda GermanyDirector
|
GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029716 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,988 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:05 UTC |
MOREL DONALD E JRDirector
|
GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029704 · doc4.xml · nonDerivative · entry 2 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,871 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:05 UTC |
MOREL DONALD E JRDirector
|
GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029704 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,653 F1 · balance_after: This total corrects the total number of shares beneficially owned due to a clerical error in the Reporting Person's Form 4 previously filed on May 20, 2019. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:07 UTC |
SCHADE CHRISTIAN SDirector
|
GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029710 · doc4.xml · nonDerivative · entry 2 SCHADE CHRISTIAN S · CIK 0001214496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,174 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:07 UTC |
SCHADE CHRISTIAN SDirector
|
GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029710 · doc4.xml · nonDerivative · entry 1 SCHADE CHRISTIAN S · CIK 0001214496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,956 Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:21 UTC |
ESSIG STUARTDirector
|
SaleCommon Stock | 2,087 | $52.07 | $108,679.06 |
DisclosureSEC source: 0001209191-20-029190 · doc4.xml · nonDerivative · entry 1 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,065,660 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $51.80 to $52.155. F2 · balance_after: On September 26, 2019, in accordance with the provisions of Grantor Retained Annuity Trust (the "GRAT"), 29,170 shares were distributed from the GRAT to the reporting person. F3 · balance_after: On July 18, 2019, 750,000 shares were transferred to a GRAT. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,978 | $0.00 Strike: $43.68 | $0.00 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · derivative · entry 13 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,660 Underlying: Common Stock · 4,978 shares Expires 2025-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/13/2017. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,446 | $0.00 Strike: $38.43 | $0.00 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · derivative · entry 12 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,446 shares Expires 2024-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 100% of the shares of stock options will vest on the third anniversary of the grant date of 12/01/2016. F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,486 | $0.00 Strike: $32.59 | $0.00 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · derivative · entry 11 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,486 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/14/2016. F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,420 | $0.00 Strike: $26.87 | $0.00 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · derivative · entry 10 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,420 shares Expires 2023-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015. F3 · balance_after: This stock option was previously reported as covering 1,047 shares of common stock at an exercise price of $62.10 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015. F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
SaleCommon Stock | 5,486 | $52.59 | $288,508.74 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 8 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Exercise / conversionCommon Stock | 5,486 | $32.59 | $178,761.31 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 7 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
SaleCommon Stock | 10,446 | $52.59 | $549,355.14 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 6 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Exercise / conversionCommon Stock | 10,446 | $38.43 | $401,387.55 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 5 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
SaleCommon Stock | 4,978 | $52.59 | $261,793.02 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Exercise / conversionCommon Stock | 4,978 | $43.68 | $217,439.04 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
SaleCommon Stock | 2,420 | $52.59 | $127,267.80 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Exercise / conversionCommon Stock | 2,420 | $26.87 | $65,013.30 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.